Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Aug;164(2):268-74.
doi: 10.1016/j.ahj.2012.05.005.

Randomized trial of lottery-based incentives to improve warfarin adherence

Affiliations
Randomized Controlled Trial

Randomized trial of lottery-based incentives to improve warfarin adherence

Stephen E Kimmel et al. Am Heart J. 2012 Aug.

Abstract

Background: Poor adherence to medications is a major cause of morbidity and inadequate drug effectiveness. Efforts to improve adherence have typically been either ineffective or too complex to implement in clinical practice. Lottery-based incentive interventions could be a scalable approach to improving adherence.

Methods: This was a randomized, controlled clinical trial of a daily lottery-based incentive in patients on warfarin stratified by baseline international normalized ratio (INR). The trial randomized 100 patients to either a lottery-based incentive or no lottery intervention. Main outcome was out-of-range INRs.

Results: Over 6 months, the overall percentage of out-of-range INRs did not differ between the 2 arms (mean 23.0% in lottery arm and 25.9% in control arm, adjusted odds ratio [OR] 0.93, 95% CI 0.62-1.41). However, among the a priori subgroup with a baseline INR below therapeutic range, there was a significant reduction in out-of-range INR in the lottery arm versus the control arm (adjusted OR 0.39, 95% CI 0.25-0.62), whereas there was no such effect among those with therapeutic INRs at baseline (adjusted OR 1.26, 95% CI, 0.76-2.09, P value for interaction = .0016). Among those with low INR at baseline, there was a nonsignificant 49% reduction in the odds of nonadherence with the intervention (OR 0.51, 95% CI 0.23-1.14).

Conclusions: Although a lottery-based intervention was not associated with a significant improvement in anticoagulation control among all study participants, it improved control among an a priori group of patients at higher risk for poor adherence.

Trial registration: ClinicalTrials.gov NCT00904982.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient flowchart.
Figure 2
Figure 2
A, Out-of-range INRs by study arm and a priori subgroup. Predictive probability of INR out of range. Primary outcome of out-of-range INRs by study arm and a priori subgroups of those with INR below range and INR within range at baseline. Results are presented as predicted probabilities from GEE logistic regression models. B, Nonadherence by study arm and a priori subgroup. Predictive probability of nonadherence. Secondary outcome of adherence by study arm and a priori subgroups of those with INR below range and INR within range at baseline. Results are presented as predicted probabilities from GEE logistic regression models.

References

    1. Peterson AM, Takiya L, Finley R, et al. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60:657–65. - PubMed
    1. Haynes RB. Improving patient adherence: state of the art, with a special focus on medication taking for cardiovascular disorders. In: Burke LE, Ockene IS, editors. Compliance in Healthcare and Research. Armonk, NY: Futura Publishing Company, Inc; 2001. pp. 3–21.
    1. Kimmel SE, Chen Z, Price M, et al. The influence of patient adherence on anticoagulation control with warfarin. Arch Intern Med. 2007;167:229–35. - PubMed
    1. Parker CS, Chen Z, Price M, et al. Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study. J Gen Intern Med. 2007;22:1254–9. - PMC - PubMed
    1. Go AS, Hylek EM, Borowsky LH, et al. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the Anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999;131:927–34. - PubMed

Publication types

Associated data